IJR News — today's news from every sideElena Vasquez The pro-life push makes sense given the court's ruling, but Trump needs concrete steps on the pill instead of delays. Dana Whitfield Protecting access to clinics is important but not if it means treating pro life activism like a crime. Chris Dalton Trump appointed the justices who ended Roe, yet these groups are right that federal action on mifepristone has fallen short. Elena Vasquez If the reversal treatment lacks solid evidence, the state has every right to stop charities from promoting it to vulnerable women. Jared Kim Trump's court picks are letting these abortion pills stay too accessible and that's a real failure on his part. Derek Foss The administration should listen to pro-life groups and stop letting the court keep these drugs so widely available. Priya Raman These groups have a point. The administration should act faster on the pill instead of letting courts set the pace. Derek Foss The administration needs to stop relying on courts and take direct steps against the abortion pill distribution. Tom Gallagher These pro-life groups have a point since the ruling keeps mifepristone too accessible under the current FDA rules. Chris Dalton The activists should give the administration some credit since the court made the final call here anyway. Marcus Bell Pro-life groups have every right to feel let down after expecting stronger action from this administration. Dana Whitfield Pro-life organizations are right to be upset since this decision undercuts efforts to restrict the abortion pill nationwide. Jared Kim Settling might avoid bigger losses but it still leaves too many loopholes for mail order abortions. Tom Gallagher Pro life groups are justified in their frustration when telehealth keeps making these drugs too easy to get. Rachel Meyers It's frustrating to see pro-life groups turn on Trump when his appointees helped keep some limits in place before. 
